Synthesis, crystal structure and antimicrobial activities of two isomeric gold(I) complexes with nitrogen-containing heterocycle and triphenylphosphine ligands, [Au(L)(PPh3)] (HL = pyrazole and imidazole)

Two isomeric gold(I)-triphenylphosphine complexes with nitrogen-containing heterocycles, [Au(L)(PPh3) (HL = pyrazole (1), imidazole (2)) were isolated as colorless cubic crystals for 1 and colorless plate crystals for 2, respectively. The crystal structures of 1 and 2 were determined by single-crystal X-ray diffraction. These complexes were also fully characterized by complete elemental analyses, thermogravimetric/differential thermal analyses (TG/DTA) and FT-IR in the solid state and by solution NMR (31P, 1H and 13C) spectroscopy and molecular weight measurements in acetone solution. These complexes consisted of a monomeric 2-coordinate AuNP core both in the solid state and in solution. The molecular structures of 1 and 2 were compared with those of related gold(I) complexes, [Au(1,2,3-triz)(PPh3)] (3, Htriz = triazole), [Au(1,2,4-triz)(PPh3)]2 (4) as a dimer through a gold(I)-gold(I) bond in the solid state, and [Au(tetz)(PPh3)] (5, Htetz = tetrazole). Selective and effective antimicrobial activities against two gram-positive bacteria (B. subtilis, S. aureus) and modest activities against one yeast (C. albicans) found in these gold(I) complexes 1-4 are noteworthy, in contrast to poor activities observed in the corresponding silver(I) complexes.     

Some complexes of 2.3-Dimercaptopropanol (BAL) with gold(I) and gold(III)

2, 3-Dimercaptopropanol (BAL) reacted with the tetrachloroaurate ion in solution to form a series of insoluble polymers of definite stoichiometry. Both gold(I) and gold(III) have been identified in these compounds. Reaction of BAL with the tetrabromoaurate ion and with thiomalic acid and D-penicillamine complexes of gold also produced insoluble precipitates. However, with an L-cysteine complex of gold no precipitate was isolated, although there was evidence of replacement of cysteine with BAL. The implications of these results for the use of BAL in cases of gold toxicity are discussed     

Synthesis, NMR study, and X-ray structure of 2-(N-methyl-N′-cyano-N″-ethylguanidino) thiotriophenylphosphinegold(I)

The reaction between cimetidine in a methanolic solution of KOH and a dichloromethane solution of PPh₃AuCl affords a new compound with formula [L-Au-PPh₃] (I) (L = 2-(N-methyl-N′-cyano-N″-ethylguanidino)thiolate), the thiolato ligand resulting from cleavage of one of the thioether bonds of cimetidine. (I) has been characterized by elemental analysis, infrared, and ¹H and ¹³C NMR spectroscopy. Single crystal x-ray structure determination shows that the gold atom is linearly coordinated by a phosphine ligand (Au-P 2.258(1) Å) and by an S atom (Au-S 2.282(1) Å) of the thiolato ligand. Crystal data: triclinic, space group P with a = 8.848(1), b = 11.343(3), c = 12.107(3)Å, = 87.63(1), β = 85.24(1), γ = 79.89(1)°, R = 0.024 for 3673 reflections with I > 3 δ (I).     

Bis(L-cysteinato)gold(I): chemical characterization and identification in renal cortical cytoplasm.

L-Cysteinatogold(I) was prepared by the reaction of L-cysteine with KAuBr4 in acidic media and its solubility determined from pH 4 to 10. The solubility at pH 7.4 and 37 degrees C is 1 microM. In the presence of excess cysteine, the solubility increases because of formation of bis(L-cysteinato)gold(I). The equilibrium-constant for formation of the bis complex is 2.1 +/- 0.4 X 10(-3), which at pH 7.4 CORRESPONDs to an apparant formation constant of 4.4 X10(4). The formation of the bis adduct was confirmed by chromatographic separation of the products of the reaction between [35S]-L-cysteine and Na2AuTM. This complex elutes with Kav = 1.15 which allows it to be distinguished from other gold thiolates that might form in vivo. The bis(cysteinato)gold(I) complex is shown to be present in kidney cytosol isolated from rats given Na2AuTM in vivo. When additional cysteine is added to the cytosol in vitro, the peak at 1.15 is increased, but if glutathione is added, the low molecular weight gold elutes at Kav = 1.00, which is taken as evidence for the existence of bis(cysteinato)gold(I) in the cytosol preparation. The amount of gold present as bis(cysteinato)gold(I) after 4 different dose schedules has been measured and found to increase with the total cytosol gold concentration. L-Cysteinatogold(I) does not dissolve in the presence of bovine serum albumin to form an adduct.     

Synthesis and X-ray crystal structure determination of two pseudopolymorphic forms of μ-[1,2-bis(diphenylphosphino)ethane] bis [chlorogold(I)]: a digold(I) DNA binder

An improved synthetic route to the linearly coordinated digold(I) complex, μ-[1,2-bis(diphenylphosphino)ethane]bis[chlorogold(I)], is reported. This complex crystallizes in two pseudopolymorphic forms from a chloroform/methylene chloride solution; the crystal and molecular structures of both are discussed and compared. In both crystal forms the potentially chelating diphenylphosphinoethane (dppe) ligand instead coordinates to two separate gold atoms. The coordination environment of each gold atom is linear in both pseudopolymorphs and the structures display normal goldchloride and goldphosphorus bond distances. On the molecular level, the pseudopolymorphs differ fundamentally by a twist about one of the gold phosphorous bonds with the phosphorous atoms of the dppe ligand adopting a transoid orientation relative to one another in both polymorphs. These conformations thus place the intramolecular gold atoms 6 Å apart and preclude intramolecular AuAu bonding interactions. As has been observed for related gold(I) complexes there are short intermolecular AuAu contacts of the order of 3.2 Å present in both structures. The conformational flexibility of the gold complex relative to its observed biological activity as a DNA binder is discussed.     

Redox and ligand exchange reactions of potential gold(I) and gold(III)-cyanide metabolites under biomimetic conditions

Biomimetic pathways for the oxidation of [Au(CN)(2)](-), a gold metabolite, and further cyanation of the gold(III) products to form Au(CN)(4)(-) were investigated using 13C NMR and UV-Visible spectroscopic methods. Hypochlorite ion, an oxidant released during the oxidative burst of immune cells, was employed. The reaction generates mixed dicyanoaurate(III) complexes, trans-[Au(CN)(2)X(2)](-), where X(-) represents equilibrating hydroxide and chloride ligands, and establishes the chemical feasibility of dicyanoaurate oxidation by OCl(-) to gold(III) species. This oxidation reaction suggests a new procedure for synthesis of H[Au(CN)(2)Cl(2)]. Reaction of trans-[Au(CN)(2)X(2)](-) (X(-)=Cl(-) and Br(-)) or [AuCl(4)](-) with HCN in aqueous solution at pH 7.4 leads directly to [Au(CN)(4)](-) without detection of the anticipated [Au(CN)(x)X(4-x)](-)intermediates, which is attributed to the cis- and trans-accelerating effects of the cyanides. The reduction of [Au(CN)(4)](-) by glutathione and other thiols is a complex, pH-dependent process that proceeds through two intermediates and ultimately generates [Au(CN)(2)](-). These studies provide further insight into the possible mechanisms of an immunogenically generated gold(I)/gold(III) redox cycle in vivo.     

Two new mononuclear gold(I)-nitrogen [N,N′-di(2,6-methyl)phenylformamidine] complexes: Syntheses and crystal structures

Two gold(I) mononuclear complexes have been prepared by reacting gold(I) tetrahydrothiophene with N,N′-di(2,6-methyl)phenylformamidine. The neutral complex [N,N′-di(2,6-methyl)phenylformamidine)-gold(I) chloride (C₁₇H₂₀AuClN₂) (1), crystallizes in the triclinic group while the cationic [N,N′-di(2,6-methyl)phenylformamidine](tetrahydrothiophene)-gold(I) (C₂₁H₂₈AuN₂S) (2) crystallizes with a nitrate anion in the monoclinic group P2(1)/n. Both compounds are good starting materials for synthetic gold chemistry.     

Gold(I) alkynyl complexes containing a flexible, biphenyl-derived bis(alkyne)

2,2′-Diethynylbiphenyl was prepared in a three step sequence from commercially available 2,2′-bis(bromomethyl)biphenyl and subsequently reacted with the phosphinegold(I) complexes [AuCl(P)] (P = PEt₃, PCy₃, P^tBu₃, PPh₃, PTA) in the presence of base to give the bis(alkynyl) gold(I) complexes [(P)Au(deb)Au(P)] in good yields as air-stable solids. The compounds were fully characterized spectroscopically and the solid state structures of 2,2′-diethynylbiphenyl as well as the PEt₃ complex were determined by X-ray diffraction. Both solution and solid-state luminescence spectra of the gold complexes were recorded.     

Lipophilic gold(I) complexes with 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione moieties: synthesis and their cytotoxic and antimicrobial activities

Novel lipophilic gold(I) complexes containing 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione derivatives were synthesized and characterized by IR, high resolution mass spectrometry, and ¹H, ¹³C ³¹P NMR. The cytotoxicity of the compounds was evaluated considering cisplatin and/or auranofin as reference in different tumor cell lines: colon cancer (CT26WT), metastatic skin melanoma (B16F10), breast adenocarcinoma (MCF-7), cervical carcinoma (HeLa), glioblastoma (M059 J). Normal human lung fibroblasts (GM07492-A) and kidney normal cell (BHK-21) were also evaluated. The gold(I) complexes were more active than their respective free ligands and cisplatin. Furthermore, antibacterial activity was evaluated against Gram-positive bacteria Staphylococcus aureus ATCC 25213, Staphylococcus epidermidis ATCC 12228 and Gram-negative bacteria Escherichia coli ATCC 11229 and Pseudomonas aeruginosa ATCC 27853 and expressed as the minimum inhibitory concentration (MIC). The complexes exhibited lower MIC values when compared to the ligands and chloramphenicol against Gram-positive bacteria and Gram-negative bacteria. Escherichia coli was sensitive one to the action of gold(I) complexes.     

Structures and luminescence of mononuclear and dinuclear base-stabilized gold(I) pyrazolate complexes

The mono- and dinuclear base-stabilized gold(I) pyrazolate complexes, (PPh₃)Au(μ-3,5-Ph₂pz)) (1), (TPA)Au(3,5-Ph₂pz), TPA=1,3,5-triaza-7-phophaadamantane (2), [(PPh₃)₂Au(μ-3,5-Ph₂pz)]NO₃ (3) and [(dppp)Au(μ-3,5-Ph₂pz)]NO₃, dppp=bis(diphenylphosphino)propane (4), have been synthesized and structurally characterized. The mononuclear gold(I) complexes 1 and 2 show intermolecular Au?Au interactions of 3.1540(6) and 3.092(6) Å, while the dinuclear gold(I) complexes 3 and 4 show an intramolecular Au?Au distances of 3.3519(7) and 3.109(2) Å, respectively, typical of an aurophilic attraction. Complexes 1-4 exhibit luminescence at 77 K when excited with ca. 333 nm UV light with an emission maximum at ca. 454 nm. The emission has been assigned to ligand-to-metal charge transfer, LMCT, based upon the vibronic structure that is observed.     

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

A series of new gold(I) and gold(III) complexes based on the saccharinate (sac) ligand, namely M[Au(sac)₂] (with M being Na⁺, K⁺ or NH₄⁺), [(PTA)Au(sac)], K[Au(sac)₃Cl] and Na[Au(sac)₄], were synthesized and characterized, and some aspects of their biological profile investigated. Spectrophotometric analysis revealed that these gold compounds, upon dissolution in aqueous media, at physiological pH, manifest a rather favourable balance between stability and reactivity. Their reactions with the model proteins cytochrome c and lysozyme were monitored by mass spectrometry to predict their likely interactions with protein targets. In the case of disaccharinato gold(I) complexes, cytochrome c adducts bearing four coordinated gold(I) ions were preferentially formed in high yield. In contrast, [(PTA)Au(sac)] (PTA = 1,3,5-triaza-7-phosphaadamantane) turned out to be poorly effective, only producing a mono-metalated adduct in very low amount. In turn, the gold(III) saccharinate derivatives were less reactive than their gold(I) analogues: K[Au(sac)₃Cl] and Na[Au(sac)₄] caused moderate protein metalation, again with evidence of formation of tetragold adducts. Finally, the above mentioned gold compounds were challenged against the reference human tumor cell line A2780S and its cisplatin resistant subline A2780R and their respective cytotoxic profiles determined. [(PTA)Au(sac)] turned out to be highly cytotoxic whereas moderate cytotoxicities were observed for the gold(III) complexes and only modest activities for disaccharinato gold(I) complexes. The implications of these results are thoroughly discussed in the light of current knowledge on gold based drugs.     

Modeling of Progesterone Release from Poly(3-Hydroxybutyrate) (PHB) Membranes

Poly(3-hydroxybutyrate) (PHB) biodegradable polymeric membranes were evaluated as platform for progesterone (Prg)-controlled release. In the design of new drug delivery systems, it is important to understand the mass transport mechanism involved, as well as predict the process kinetics. Drug release experiments were conducted and the experimental results were evaluated using engineering approaches that were extrapolated to the pharmaceutical field by our research group. Membranes were loaded with different Prg concentrations and characterized by scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR). SEM images showed that membranes have a dense structure before and after the progesterone addition. DSC and FTIR allowed determining the influence of the therapeutic agent in the membrane properties. The in vitro experiments were performed using two different techniques: (A) returning the sample to the receptor solution (constant volume of the delivery medium) and (B) extracting total volume of the receptor solution. In this work, we present a simple and accurate “lumped” second-order kinetic model. This lumped model considers the different mass transport steps involved in drug release systems. The model fits very well the experimental data using any of the two experimental procedures, in the range 0?≤?t?≤?∞ or 0?≤?M _t ?≤?M _∞. The drug release analysis using our proposed approaches is relevant for establishing in vitro–in vivo correlations in future tests in animals.     

Tuning the Au(I)-mediated inhibition of cathepsin B through ligand substitutions

It has been over 80 years since the antiarthritic properties of gold(I) complexes were first recognized. However, a detailed understanding of their mechanism of action has been slow to develop. One likely biological target of gold(I) is the cathepsin family of lysosomal cysteine proteases, enzymes involved in the inflammation and joint destruction that are hallmarks of rheumatoid arthritis (RA). We have previously shown that analogs of auranofin, a clinically available antiarthritic drug, inhibit cathepsin B. In this study, the extent to which the steric and electronic properties of the phosphine ligand can be modified to obtain enhanced potency against cathepsin B is investigated.     

Studies of the interaction of potassium(I), calcium(II), magnesium(II), and copper(II) with cyclosporin A

Metal ion binding properties of the immunosuppressant drug cyclosporin A have been investigated. Complexation studies in acetonitrile solution using 1H NMR and CD spectroscopy yielded 1:1 metal-peptide binding constants (log(10)K) for potassium(I), <1, magnesium(II), 4.8+/-0.2, and calcium(II), 5.0+/-1.0. The interaction of copper(II) with cyclosporin A in methanol was investigated with UV/visible and electron paramagnetic resonance (EPR) spectroscopy. No complexation of copper(II) was observed in neutral solution. In the presence of base, monomeric copper(II) complexes were detected. These results support the possibility that cyclosporin A has ionophoric properties for biologically important essential metal ions.     

Bis( -cysteinato)gold(I): Chemical characterization and identification in renal cortical cytoplasma

-Cysteinatogold(I) was prepared by the reaction of -cysteine with KAuBr₄ in acidic media and its solubility determined from pH 4 to 10. The solubility at pH 7.4 and 37° C is 1 μM. In the presence of excess cysteine, the solubility increases because of formation of bis( -cysteinato)gold(I). The equilibrium constant for formation of the bis complex is 2.1 ± 0.4 × 10⁻³, which at pH 7.4 corresponds to an apparant formation constant of 4.4 × 10⁴. The formation of the bis adduct was confirmed by chromatographic separation of the products of the reaction between [³⁵S]- -cysteine and Na₂AuTM. This complex elutes with K_av = 1.15 which allows it to be distinguished from other gold thiolates that might form in vivo. The bis(cysteinato)gold(I) complex is shown to be present in kidney cytosol isolated from rats given Na₂AuTM in vivo. When additional cysteine is added to the cytosol in vitro, the peak at 1.15 is increased, but if glutathione is added, the low molecular weight gold elutes at K_av = 1.00, which is taken as evidence for the existence of bis(cysteinato)gold(I) in the cytosol preparation. The amount of gold present as bis(cysteinato)gold(I) after 4 different dose schedules has been measured and found to increase with the total cytosol gold concentration. -Cysteinatogold(I) does not dissolve in the presence of bovine serum albumin to form an adduct.     

Thermodynamics of the complex formation in pyridine between gold(i) and ligands coordinating via N,P, As or Sb

The thermodynamics of complex formation between gold(I) and the ligands tricyclohexylphosphine, triphenylamine, -phosphine, -arsine, and -stibine has been determined in pyridine solution by potentiometric and calorimetric measurements. As expected, the very soft gold(I) displays a more marked stability (b)-sequence N ⪡ P > As > Sb than its lighter, and less soft, congener silver(I). Like all complexes of these ligands so far studied, the present ones are strongly enthalpy stabilized while the entropy changes are generally unfavourable. The stepwise entropy changes show quite peculiar differences between the various ligands, however. The thermodynamics of these complexes is in striking contrast to that of the gold(I) halido complexes in pyridine which are strongly entropy stabilized, while the enthalpy changes are small.     

Inhibition of several enzymes by gold compounds. II. beta-Glucuronidase, acid phosphatase and L-malate dehydrogenase by sodium thiomalatoraurate (I), sodium thiosulfatoaurate (I) and thioglucosoaurate (I)

Bovine liver beta-D-glucuronide glucuronohydrolase, EC 3.2.1.32), wheat germ acid phosphatase (orthophosphoric monoesterphosphohydrolase, EC 3.1.3.2) and bovine liver L-malate dehydrogenase (L-malate: NAD oxidoreductase, EC 1.1.1.37) were inhibited by a series of gold (I) complexes that have been used as anti-inflammatory drugs. Both sodium thiosulfatoaurate (I) (Na AuTs) and sodium thiomalatoraurate (NaAuTM) effectively inhibited all three enzymes, while thioglucosoaurate (I) (AuTG) only inhibited L-malate dehydrogenase. The equilibrium constants (K1) ranged from nearly 4000 microM for the NaAuTM-beta-glucuronidase interaction to 24 microM for the NaAuTS-beta-glucuronidase interaction. The rate of covalent bond formation (kp) ranged from 0.00032 min-1 for NaAuTM-beta-glucuronidase formation to 1.7 min-1 for AuTG-L-malate dehydrogenase formation. The equilibrium data shows that the gold (I) drugs bind by several orders lower than the gold (III) compounds, suggesting a significantly stronger interaction between the more highly charged gold ion and the enzyme. Yet the rate of covalent bond formation depends as much on the structure of the active site as upon the lability of the gold-ligand bond. It was also observed that the more effective the gold inhibition the more toxic the compound.     

Au(2)(micro-G)(micro-dmpe)].(KBr)(0.75) 2H(2)O, a cyclic dinuclear gold(I) complex with an N3,N9-bridging coordination mode of guanine and aurophilic interactions: synthesis, X-ray crystal structure and luminescence properties (dmpe=1,2-bis(dimethylphosphino)ethane and G=guaninato dianion)

The digold complex [Au(2)(micro-G)(micro-dmpe)](KBr)(0.75) x 2H(2)O (dmpe=1,2-bis(dimethylphosphino)ethane (1)) has been prepared by nucleophilic attack of the guaninate dianion on the gold(I) atoms of [(AuBr)(2)(micro-dmpe)] and has been characterised by X-ray crystallography and spectroscopic studies. The structure of 1 consists of dinuclear nine-membered ring molecules, K(+) cations, Br(-) anions and water molecules, all of them involved in either weak K....O or hydrogen bonding interactions. Within the cyclic dinuclear molecules, gold(I) atoms are bridged on one side by the diphosphine ligand and on the other side by a doubly deprotonated guaninate anion coordinated through neighbouring N3 and N9 nitrogen atoms, with gold(I)....gold(I) interactions of 3.030(2) A. This is the first X-ray example showing an N3,N9-bridging mode for guanine. There are two types of K(+) cations in the structure, K1 and K2. The former interacts with water molecules to form a unique [K(H(2)O)(3)(micro-H(2)O)(2)K(H(2)O)(3)](2+) dipotassium unit whereas K2 interact with the O6 atom of the guaninate ligands and oxygen atoms of the dipotassium unit leading to a chain running along the c-axis. Each chain is interdigitated with four neighbouring ones to give rise to an intricate network in which Br1, Br2 and [K(H(2)O)(3)(micro-H(2)O)(2)K(H(2)O)(3)](2+) fit snugly into cavities defined by digold molecules. Complex 1 luminescence at room temperature and 77 K in the solid state with excitation maxima at 385 nm and emission maxima at 451.8 and 448.7 nm, respectively. The emission spectrum of a saturated solution of 1 in DMSO (dimethyl sulfoxide) shows the maximum at about 440 nm.     

Interactions of selected gold(III) complexes with calf thymus DNA

DNA represents the primary target for platinum antitumor metal complexes and is the probable target for newly developed cytotoxic gold(III) complexes. To test this hypothesis the reactions with calf thymus DNA of five representative gold(III) complexes--namely [Au(en)(2)]Cl(3), [Au(dien)Cl]Cl(2), [Au(cyclam)](ClO(4))(2)Cl, [Au(terpy)Cl]Cl(2) and [Au(phen)Cl(2)]Cl--were analyzed in vitro through various physicochemical techniques including circular dichroism, absorption spectroscopy, DNA melting, and ultradialysis. It is shown that all tested complexes interact with DNA and modify significantly its solution behavior. The solution conformation of DNA is affected to variable extents by the individual complexes as shown by CD titration experiments. Notably, in all cases, the gold(III) chromophore is not largely perturbed by addition of calf thymus DNA ruling out occurrence of gold(III) reduction. Ultradialysis experiments point out that the binding affinity of the various complexes for the DNA double helix is relatively low; in most cases the gold(III)/DNA interaction is electrostatic in nature and reversible. The implications of these findings for the mechanism of action of antitumor gold(III) complexes are discussed.     

Structure and bonding of gold(I) and gold(III) nucleosides studied by 197Au Mössbauer spectroscopy

¹⁹⁷Au Mössbauer spectra of the series of complexes of gold(I), Au(nucl)₂Cl and gold(III), Au(nucl)Cl₃, Au(nucl - H⁺)Cl₂ and Au(nucl)₂Cl₃ were measured at 4.2 K, (nucl = nucleoside, e.g. guanosine(guo), inosine(ino), triacetylguanosine-(trguo) and triacetylinosine(trino)). It is concluded from the spectra that the gold(I) nucleosides have linear ClAuN coordination, with one coordinated nucleoside molecule per gold(I) ion, bound via the N(7) atom. The σ-donor strength of the guo ligand is somewhat higher than that of the ino ligand. The complexes Au(ino)Cl₃ and Au(guo)Cl₃, in the series Au(nucl)Cl₃, have significantly higher IS and QS values than the corresponding complexes with the triacetylnucleosides, Au(trino)Cl₃ and Au(trguo)Cl₃. This may be explained by a weak O(6)-interaction with gold(III), in a nearly trigonal bipyramidal configuration in the former case and by the presence of the strongly electron withdrawing acetyl groups in the latter, which reduces the donor strength of their N(7) atoms. The complexes of the Au(nucl - H⁺)Cl₂ series all appear to have a polymeric structure. The gold(III) ion is bound to the N(7) atom and the O(6) or the N(1) atom of the nucleosides. Finally, the Mössbauer spectra of the series Au(nucl)₂)Cl₃ can only be explained by assuming approximately octahedral AuN₂Cl₄ structures, with bridging chlorine atoms.